MARKET

SIEN

SIEN

Sientra Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.170
-0.020
-1.68%
After Hours: 1.170 0 0.00% 16:00 05/16 EDT
OPEN
1.180
PREV CLOSE
1.190
HIGH
1.250
LOW
1.145
VOLUME
493.95K
TURNOVER
0
52 WEEK HIGH
9.14
52 WEEK LOW
1.145
MARKET CAP
73.25M
P/E (TTM)
-1.0643
1D
5D
1M
3M
1Y
5Y
Stocks That Hit 52-Week Lows On Monday
  On Monday, 198 companies reached new 52-week lows.
Benzinga · 4h ago
Sientra (SIEN) Reports Q1 Loss, Tops Revenue Estimates
Sientra (SIEN) delivered earnings and revenue surprises of -11.54% and 5.67%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 4d ago
BRIEF-Sientra Files For Mixed Shelf Of Up To $100 Million - SEC Filing
reuters.com · 4d ago
Recap: Sientra Q1 Earnings
Sientra (NASDAQ:SIEN) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Sientra missed estimated earnings by 20.83%, reporting an EPS of $-0.29 versus an estimate of ...
Benzinga · 4d ago
Sientra Q1 EPS $(0.29) Misses $(0.24) Estimate, Sales $21.40M Beat $20.84M Estimate
Sientra (NASDAQ:SIEN) reported quarterly losses of $(0.29) per share which missed the analyst consensus estimate of $(0.24) by 20.83 percent. This is a 190 percent decrease over losses of $(0.10) per share from the same
Benzinga · 4d ago
Sientra GAAP EPS of -$0.29 misses by $0.06, revenue of $21.4M beats by $0.56M
Sientra press release (NASDAQ:SIEN): Q1 GAAP EPS of -$0.29 misses by $0.06. Revenue of $21.4M (+16.9% Y/Y) beats by $0.56M. Gross margins of 60%, reflecting strong reconstruction performance and improved
Seekingalpha · 4d ago
-- Earnings Flash (SIEN) SIENTRA Posts Q1 Revenue $21.4M, vs. Street Est of $20.8M
MT Newswires · 4d ago
Sientra Q1 2022 Earnings Preview
Sientra (NASDAQ:SIEN) is scheduled to announce Q1 earnings results on Thursday, May 12th, after market close. The consensus EPS Estimate is -$0.24 and the consensus Revenue Estimate is $20.84M (-10.3%
Seekingalpha · 5d ago
More
No Data
Learn about the latest financial forecast of SIEN. Analyze the recent business situations of Sientra Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 7 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

57.14%Strong Buy
42.86%Buy
0.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average SIEN stock price target is 6.83 with a high estimate of 10.00 and a low estimate of 5.00.
High10.00
Average6.83
Low5.00
Current 1.170
EPS
Actual
Estimate
-0.28-0.21-0.14-0.07
Q2 2021
Q3 2021
Q4 2021
    0
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 178
Institutional Holdings: 66.41M
% Owned: 106.07%
Shares Outstanding: 62.61M
TypeInstitutionsShares
Increased
35
3.90M
New
18
1.64M
Decreased
37
5.12M
Sold Out
21
1.59M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+0.39%
Healthcare Equipment & Supplies
-0.13%
Key Executives
Chairman/Executive Director
Caroline Van Hove
President/Chief Executive Officer/Director
Ronald Menezes
Chief Financial Officer
Andrew Schmidt
Chief Compliance Officer/General Counsel
Oliver Bennett
Vice President/Controller
Valerie Miller
Vice President - Research & Development
Denise Dajles
Director
Keith Sullivan
Independent Director
Nori Ebersole
Independent Director
Irina Erenburg
Independent Director
Mary Fisher
Independent Director
Kevin O'Boyle
Independent Director
Philippe Schaison
No Data
No Data
About SIEN
Sientra, Inc. is a medical aesthetics company. The Company's primary products are silicone gel breast implants for use in breast augmentation and breast reconstruction procedures, which it offers in over 400 variations of shapes, sizes and textures. The Company sells its breast implants and breast tissue expanders, or breast products to plastic surgeons. Its breast implants are primarily used in elective procedures, which are generally performed on a cash-pay basis. Implant Texture provides texturing on the implant shell that is designed to reduce the incidence of malposition, rotation and capsular contracture. The Company also offers breast tissue expanders for reconstruction procedures predominantly to hospitals and surgery centers, and its BIOCORNEUM scar management products to plastic surgeons, dermatologists and other specialties. The Company's brands also include OPUS, Luxe, Curve, AlloX2, Dermaspan and Softspan.

Webull offers kinds of Sientra Inc stock information, including NASDAQ:SIEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SIEN stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading SIEN stock methods without spending real money on the virtual paper trading platform.